Iranian Journal of Allergy, Asthma and Immunology (Apr 2021)

Generalized Bullous Fixed Drug Eruption to Fluconazole with Positive Patch Testing and Confirmed Tolerance to Itraconazole

  • Michael Makris,
  • Christos Fokoloros,
  • Anna Syrmali,
  • Zoi Tsakiraki,
  • Vasileia Damaskou,
  • Evangelia Papadavid

DOI
https://doi.org/10.18502/ijaai.v20i2.6081
Journal volume & issue
Vol. 20, no. 2

Abstract

Read online

Generalized bullous fixed drug eruption (GBFDE) is a specific variant of fixed drug eruption that belongs to severe cutaneous adverse reactions (SCARs) and its diagnosis is based mainly on clinical course and especially on the reoccurrence of typical bullous lesions in previous and new sites after re-administration of the offending drug. We present a well-documented case of fluconazole-induced GBFDE, with a positive patch test to fluconazole (30% weight/volume preparation) and clinical tolerance to itraconazole proven by negative oral provocation. Even in SCARs, patch testing represents a useful diagnostic tool, while oral provocation remains the gold standard in cases that an alternative but the chemically relevant drug must be administered.

Keywords